{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:46:52Z","timestamp":1782776812433,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejogrb.2026.115012","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T23:36:42Z","timestamp":1771198602000},"page":"115012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pretreatment decrease of the anti-m\u00fcllerian hormone level does not translate into the proportionally lower efficiency of ovarian stimulation in patients with haematological malignancies"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9798-9743","authenticated-orcid":false,"given":"Iuliia","family":"Brichkalevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mladova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Revina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Shevchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Kishkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Baryakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Mileyko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejogrb.2026.115012_b0005","first-page":"443","article-title":"Cancer statistics for adolescents and young adults, 2020","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"27","key":"10.1016\/j.ejogrb.2026.115012_b0010","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1200\/JCO.2011.41.0910","article-title":"International Prognostic score in Advanced-Stage Hodgkin\u2019s Lymphoma: Altered Utility in the Modern Era","volume":"30","author":"Moccia","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115012_b0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.fertnstert.2017.05.024","article-title":"Update on fertility preservation from the Barcelona International Society for Fertility Preservation\u2013ESHRE\u2013ASRM 2015 expert meeting: indications, results and future perspectives","volume":"108","author":"Martinez","year":"2017","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115012_b0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(05)70092-9","article-title":"Fertility preservation for young patients with cancer: who is at risk and what can be offered?","volume":"6","author":"Wallace","year":"2005","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115012_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115012_b0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.fertnstert.2012.04.021","article-title":"Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma\u2014evaluation by using antim\u00fcllerian hormone and retrieved oocytes","volume":"98","author":"Lawrenz","year":"2012","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115012_b0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10815-016-0689-1","article-title":"Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies","volume":"33","author":"Lekovich","year":"2016","journal-title":"J Assist Reprod Genet"},{"issue":"7","key":"10.1016\/j.ejogrb.2026.115012_b0040","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.ejogrb.2026.115012_b0045","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1470-2045(14)70334-1","article-title":"Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation","volume":"15","author":"Wallace","year":"2014","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2026.115012_b0050","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod"},{"issue":"34","key":"10.1016\/j.ejogrb.2026.115012_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/jncimonographs\/lgi026","article-title":"Anti-Mullerian Hormone: its Role in Follicular Growth Initiation and Survival and as an Ovarian Reserve Marker","volume":"2005","author":"Themmen","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115012_b0060","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.fertnstert.2021.02.006","article-title":"Oocyte vitrification for fertility preservation for both medical and nonmedical reasons","volume":"115","author":"Cobo","year":"2021","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115012_b0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115012_b0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.rbmo.2022.10.012","article-title":"Prediction of ovarian response using the automated Elecsys anti-M\u00fcllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles","volume":"46","author":"Bosch","year":"2023","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115012_b0075","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.fertnstert.2016.06.035","article-title":"High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma","volume":"106","author":"Paradisi","year":"2016","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:08:58Z","timestamp":1782774538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":15,"alternative-id":["S0301211526000783"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115012","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment decrease of the anti-m\u00fcllerian hormone level does not translate into the proportionally lower efficiency of ovarian stimulation in patients with haematological malignancies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115012"}}